[Current status of gynecologic hormone therapy. Hyperandrogen disorders].
Hammerstein
J
J
D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000188:drug therapy*; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000097:blood*; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate; D004338:Drug Combinations / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy; D013739:Testosterone / Q000097:blood
D000726:Androgen Antagonists; D000728:Androgens; D004338:Drug Combinations; D013739:Testosterone; D004997:Ethinyl Estradiol; D003687:Dehydroepiandrosterone; D017373:Cyproterone Acetate; D019314:Dehydroepiandrosterone Sulfate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D003534:Cyproterone
Derzeitiger Stand der gynäkologischen Hormontherapie. Hyperandrogene Störungen.